Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Ada + Pembro in Treatment-Naïve KRASG12C+ NSCLC Dec 15, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Dostar + CT vs Pembro + CT in NSCLC: PERLA Phase II Trial OS Dec 15, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Tepotinib’s Impact on METEX14 NSCLC: DNA, Markers, and Resistance Dec 14, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Durable Tepotinib Efficacy in Asian MET-Positive NSCLC Dec 11, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Alternating Lorlatinib & Crizotinib in ALK+ NSCLC With ALK-Inhibitor Resistance Dec 08, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Triple Therapy Shows Promise for EGFR/ALK-Mutated NSCLC Dec 08, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Lazertinib vs Gefitinib in EGFR-mutated NSCLC Dec 06, 2023
